6th Antifibrotic Drug Development Summit (AFDD)

Temi della conferenza
Returning for the 6th year, the Antifibrotic Drug Development Summit (AFDD) will host the transferrable insights you need from IPF, NASH, CKD and more in one place at one time, so you can advance the progress of your antifibrotic therapies.

Scientific organizer
Hanson Wade

Annotazioni
Speakers: Adi Mor Chief Scientific Officer Chemomab, Akshay Krishnamurty Senior Scientist, Cancer Immunology Genentech, Andrew Leask Professor University of Saskatchewan, Andrzej Krolewski Senior Investigator Joslin Diabetes Centre

https://go.evvnt.com/1241066-2?pid=4832

Ms. Jessica Durston